Revvity Inc. logo

Revvity Inc. (PKN)

Market Closed
15 Jul, 15:30
XETRA XETRA
97. 88
+1.04
+1.0739%
- Market Cap
- P/E Ratio
0.28% Div Yield
2 Volume
- Eps
96.84
Previous Close
Add Transaction
Day Range
97.26 97.88
Year Range
83.3 100
Want to track PKN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PKN closed Wednesday higher at €97.88, an increase of 1.0739% from Tuesday's close, completing a monthly increase of 1.0114% or €0.98. Over the past 12 months, PKN stock gained 13.761%.
PKN pays dividends to its shareholders, with the most recent payment made on May 08, 2026. The next announced payment will be in In 2 weeks on Aug 07, 2026 for a total of €0.07.
The last earnings report, released on May 04, 2026, missed the consensus estimates by -1.03%. On average, the company has fell short of earnings expectations by -0.6833%, based on the last three reports.
Revvity Inc. has completed 4 stock splits, with the recent split occurring on Jun 04, 2001.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).

PKN Chart

Revvity Expands Signals AI With Anthropic Claude Integration

Revvity Expands Signals AI With Anthropic Claude Integration

RVTY expands Signals AI through Anthropic's MCP ecosystem, giving scientists secure Claude access to connected R&D data and scientific context.

Zacks | 2 weeks ago
Revvity Launches Signals AI to Advance Scientific R&D Workflows

Revvity Launches Signals AI to Advance Scientific R&D Workflows

RVTY expands AI capabilities in Signals software with Signals AI, designed to help scientists turn connected R&D data into actionable insights.

Zacks | 3 weeks ago
Revvity, Inc. (RVTY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Revvity, Inc. (RVTY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Revvity, Inc. (RVTY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seekingalpha | 1 month ago

Revvity Inc. (PKN) FAQ

What is the stock price today?

The current price is €97.88.

On which exchange is it traded?

Revvity Inc. is listed on XETRA.

What is its stock symbol?

The ticker symbol is PKN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.28%.

What is its market cap?

As of today, no market cap data is available.

Has Revvity Inc. ever had a stock split?

Revvity Inc. had 4 splits and the recent split was on Jun 04, 2001.

Revvity Inc. Profile

Professional Services Industry
Industrials Sector
Prahlad R. Singh CEO
XETRA Exchange
US7140461093 ISIN
US Country
11,000 Employees
17 Jul 2026 Last Dividend
4 Jun 2001 Last Split
- IPO Date

Overview

Revvity, Inc., previously known as PerkinElmer, Inc., marks a significant name in the health sciences industry, offering comprehensive solutions, technologies, and services across the globe, including the Americas, Europe, Asia, and other international territories. With its inception in 1937 and headquarters in Waltham, Massachusetts, Revvity has grown to serve an expansive range of clients, including pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. Operating through two main segments - Life Sciences and Diagnostics - Revvity, Inc. brings forward a suite of instruments, reagents, informatics, software, and much more, catering to a wide array of testing, screening, and research needs in the health sciences sector.

Products and Services

Revvity, Inc.'s product portfolio and services are vast, covering various needs within the life sciences and diagnostics fields. Here's an overview of their most notable offerings:

  • AutoDELFIA, BACS-on-Beads, BIOCHIPs, and similar products: These are used for the testing and screening of genetic abnormalities, disorders, and diseases. They serve a critical role in early detection and screening processes for conditions such as down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
  • chemagic, Chitas, DELFIA, DELFIA Xpress, and related instruments: These instruments and technologies are essential for genomic workflows, supporting applications in oncology, immunodiagnostics, drug discovery, and more. They provide the necessary tools for researchers and healthcare practitioners to analyze and understand genetic material and protein interactions.
  • JANUS, LabChip, LifeCycle, LimsLink, and similar software and systems: Key in informatics and laboratory management, these software solutions and systems optimize the operations within laboratories, improving efficiency, data management, and processing in research and diagnostic settings.
  • Migele, MultiPROBE, NEXTFLEX, NextPrep, and other reagents and assay platforms: These products are designed for specific applications within the fields of diagnostics and life sciences research, including DNA sequencing, protein analysis, and more. They are integral to the processes of detecting, analyzing, and understanding complex biological materials.
  • T-SPOT, Twister, VariSpec, ViaCord, VICTOR 2D, Zephyr, and more brand names: Under these brand names, Revvity, Inc. offers a diverse range of products that cater to different aspects of health sciences, from diagnostic tests for infectious diseases to advanced instruments for genetic and proteomic research. Each brand specializes in a unique area of the health sciences, providing specialized tools and technologies to their respective fields.

Contact Information

Address: 77 4th Avenue
Phone: 781 663 6900